Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OTC Markets 08/27/2018 Transfer Agent Verified
They announced that they were going dark--quitting filing reports--and then they did just that.
They have absolutely NO plans to begin filing again. Even if they did, all it would show is that they are expensing all profits as payment to management/board.
This is their personal cash cow, and they couldn't care less about the investors that put their money here thinking it was a good future prospect.
I have cash that I can afford to lose tied up in this, and I will keep it there just so I have a leg to stand on in any potential legal actions.
glta!
______________________________________________________________
just my opinions, of course!
Interesting articles Max - I hope this stock makes a come back and soon - It’s obvious they are making money it’s uncool leaving us few shareholders in the dark
New old test?-PCSK9,Mirnext,miRNAs,http://www.ctmm.nl/en/downloads/projects-downloads/triumph-output-report
It is interesting: 1. Methods for predicting cardiovascular events and monitoring treatment using pcsk9 (Patent).
2. …measured plasma PCSK9 levels in a subset of participants with a sandwich enzyme linked immunosorbent assay using antibodies supplied by …
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study (June 29, 2017)
I think most of the volume on this now is coming from those who see a cheap, FDA approved stock and jump in without doing much/any DD. When they realize they bought a pet rock they sell, thus false volume.
I have two hopes: first-- an investor suit is filed against them. I think it has probably been too long for that though, and realistically, I haven't suffered enough loss to get tied up in that.
Second-- the board gets tired of messing with this and sells the company. If sales have been decent/growing, then it might justify a price between $1-2, as long as they haven't screwed up their relationship with Abbott. Could possibly bring more, since they have a FDA CRL on a submission that-- if memory serves-- could be re-filed without a pot load of work. Now that I think of it, might be interesting to do a FDA search for the company to see if there have been submissions over the past couple of years.
Third-- everything stays the way it is. It is not inconceivable that the company is doing quite well. Their test was approved and incorporated on Abbott's Assay device, and there were other companies that were working to that end. I could see the directors sitting there paying themselves well, and riding this horse till it drops. Since the company is dark we wouldn't know until the very end.
These are the scenarios I can see.
Good luck to you! I will continue to hold, as I don't really need the write off this year.
******************************************************************
just my opinions, of course
Since you are a bag-holder like me and infinitely more informed imo, what do you think are the possible outcomes? I see volumes have recently been (relatively) high, but don't want to get my hopes too high. Was hoping someone could give me the possible scenarios with this pos.
Stock has gone dark, as per prior otc filings. OTCmarkets.com shows a stop warning. Last public filing was a Form 3 in June of 2016.
IMO the only reason they haven't taken this private is for the insulating layer of liability defense a publicly traded corporation can provide. They rode shareholder money to an FDA approval, and to expand initial awareness so they could begin market penetration. Once they began to see revenues come in they began to milk it for all it was worth via pr's, reverse splits, and toxic financing. When they got it to the point that was obvious, and share sales began to dry up, they took it dark.
Now they have set their pay high, and are thus reaping the rewards of a product that should be selling well. I would be willing to bet that nearly all of the money received from product sales is being spent on "director" salary.
I never sold my shares, so I should be receiving the minimum correspondence from the company. We'll see....
Good luck to you, and all others!
**************************************************************
just my opinions, of course!
It is interesting: DEF-14A 06/23/2016… Board of Directors currently consists of five members, classified into three classes as follows: Jeffrey R. Luber and Stelios Papadopoulos, Ph.D. constitute a class I with a term ending at our annual meeting of stockholders to be held in 2018; James F. O’Connor constitutes a class II with a term ending at our 2016 annual meeting of stockholders; and Harry W. Wilcox and Paul R. Sohmer, M.D. constitute a class III with a term ending at our annual meeting of stockholders to be held in 2017. On March 25, 2016, our Board of Directors accepted the recommendation of the Nominating and Governance Committee and voted to nominate James F. O’Connor for election at the annual meeting for a term of three years to serve until the 2019 annual meeting of stockholders…Manipulation: 200 sell (-42%) ?2018 annual meeting of stockholders...?
Galectin-3: A new post-MI prognostic biomarker?https://www.mdedge.com/ecardiologynews/article/168394/acute-coronary-syndromes/galectin-3-new-post-mi-prognostic-biomarker
(BGMD)
0.38 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
- - - - -
BGMD Detailed Quote
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.
http://www.mdpi.com/1422-0067/19/2/379/htm
I want to buy shares.Anybody now why STOP t.?
Galectin-3 test in development-Alinity assay menu (Abbott).cardioSCORE? https://www.corelaboratory.abbott/sal/launchMaterial/ADD-00059733_Alinity%20ci%20International%20Assay%20Menu.pdf
FDA has recently approved the GORE® CARDIOFORM Septal Occluder to be marketed. OOOPPPSSS,,, THOUGHT THAT SAID CARDIOSCORE,, THAT FLIM FLAM BATCH OF LIES PUT OUT BY THE ''BOD'' OF THIS POS STOCK SOME YEARS BACK... ESAD YOU POS'S AT BGMD.. DIE WOULD BE BETTER. PISS ON YOUR'E GRAVES!
I think that management has decided that this is better than taking it private....for them, anyway
(BGMD)
0.38 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
- - - - -
BGMD Detailed Quote
new patent application 12/28/2017
http://www.freepatentsonline.com/y2017/0370944.html
Holy blank Batman. I had to rub my eyes to see if I was seeing straight
The 2016 annual meeting of stockholders (August 5, 2016). 2017?
There was a shareholders meeting?
Galectin-3 test under development in ADVIA Centaur XP Immunoassay System (Siemens) –test BGMD???
https://www.healthcare.siemens.nl/immunoassay/systems/advia-centaur-xp/assays
BG Medicine and Siemens Healthcare Diagnostics (Galectin-3 test)?
Galectin-3 test-Architect i 2000srAbbott and VIDAS® bioMerieux.
BGMD Mkt cup 420 000$?
Who is buying? It sure would be nice to see this one back from the grave
Thank you? For what? Did I miss something?
THANK YOU $BGMD
Sooooo.... Put the chart on 3 year. A real bummer.
Bg Medicine, Inc. (P (BGMD)
0.045 ? -0.0005 (-1.10%)
Volume: 2,500 @ 3:32:44 PM EDT ET
Bid Ask Day's Range
0.045 0.055 0.045 - 0.045
BGMD Detailed Quote
I wish they would kill it or come out with info... Can't believe this stock is still trading..
Is the company alive on life support, or dead? From what I can tell nothing found in filings, zombie website, nor calling them. Anyone here know of any new developments?
Bg Medicine, Inc. (P (BGMD)
0.047 ? 0.0 (0.00%)
Volume: 450 @ 12:29:50 PM ET
Bid Ask Day's Range
0.047 0.057 0.047 - 0.047
BGMD Detailed Quote
Bg Medicine, Inc. (P (BGMD)
0.055 ? -0.0002 (-0.36%)
Volume: 6,385 @ 11:10:16 AM ET
Bid Ask Day's Range
0.05 0.075 0.055 - 0.055
BGMD Detailed Quote
its a pos company full of liars that sold lies to sell shares.
Bg Medicine, Inc. (P (BGMD)
0.09 ? 0.02 (28.57%)
Volume: 4,285 @ 3:34:05 PM ET
Bid Ask Day's Range
0.07 0.09 0.07 - 0.09
BGMD Detailed Quote
Is this a new company selling Gal 3 test? https://www.bbisolutions.com/galectin-3.html
Bg Medicine, Inc. (P (BGMD)
0.06 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
0.057 0.11 - - -
BGMD Detailed Quote
Thought this would be viable. Boy did they pull a fast one on me... Shame on management for doing this situation wrong. Kindly respond if someone here knows of something as to current status and outlook?
Followers
|
41
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1980
|
Created
|
02/28/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |